The multilayered control of acetylation during adenovirus-based immunotherapy of cancer

Area of Science:

• Virology
• Cancer Biology
• Immunology

Background:

• Adenoviruses are potent gene delivery vectors and oncolytic viruses, prevalent in cancer virotherapy trials.
• Replication-competent adenoviruses offer therapeutic potential for diverse tumors due to efficient cellular uptake.
• Adenoviral manipulation of host cell acetylome regulation is increasingly recognized for its role in cancer treatment.

Purpose of the Study:

• To review viral processes affecting the host genome's acetylome.
• To discuss how differential acetylation impacts host antiviral defense.
• To explore combining acetylation modifiers with oncolytic adenoviruses for improved viroimmunotherapy outcomes.

Main Methods:

• Literature review of studies on adenoviruses and host cell acetylation.
• Analysis of viral mechanisms influencing host genome acetylation.
• Examination of the interplay between acetylation and antiviral immunity.

Main Results:

• Adenoviruses actively redirect or suppress host cell acetylation during replication.
• Altered acetylation patterns influence the efficacy of antiviral immune responses.
• The study highlights the potential of targeting the acetylome in cancer virotherapy.

Conclusions:

• Adenoviruses' impact on host acetylation presents therapeutic opportunities for epigenetic-driven cancers.
• Modulating acetylation alongside oncolytic adenoviruses could enhance viroimmunotherapy efficacy.
• Further research into acetylation modifiers and oncolytic adenoviruses is warranted for improved cancer treatment.